Literature DB >> 6109633

Binding of perazine to alpha 1-acid glycoprotein.

J Schley, M Siegert, B Müller-Oerlinghausen.   

Abstract

The high-affinity binding of perazine to human serum-protein (non-albumin binding) was previously investigated by gel-chromatography. The immunoelectrophoretic identification of the binding agent as alpha 1-acid glycoprotein is described here. It was demonstrated by equilibrium dialysis that the average free fraction of 3H-perazine added to 22 sera from patients before neuroleptic treatment was 3.67 +/- 0.42%, and that there was a significant correlation between the alpha 1-acid glycoprotein content and the free fraction in these serum samples. This result is in accordance with what others have found for imipramine. It is suggested that the nature of this binding should be studied in more detail, since specific binding to alpha 1-acid glycoprotein may be related to the receptor binding of perazine and possibly other drugs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109633     DOI: 10.1007/bf00874663

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Protein binding of corticoids studied by gel filtration.

Authors:  P DE MOOR; K HEIRWEGH; J F HEREMANS; M DECLERCK-RASKIN
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

2.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

3.  [Specific binding of perazine, a piperazine side-chain phenothiazine drug, to a serum protein (author's transl)].

Authors:  J Schley; M Nündel; E Riedel; B Müller-Oerlinghausen
Journal:  Arzneimittelforschung       Date:  1979

Review 4.  Binding of drugs by albumin and plasma protein.

Authors:  J J Vallner
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

5.  Hydrophobic and ionic interactions of phenothiazine derivatives with bovine serum albumin.

Authors:  J Krieglstein; W Meiler; J Staab
Journal:  Biochem Pharmacol       Date:  1972-04-01       Impact factor: 5.858

6.  [Quantitative determination of protein binding of drugs by gel filtration].

Authors:  J Krieglstein; G Kuschinsky
Journal:  Arzneimittelforschung       Date:  1968-03

7.  Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals.

Authors:  M Brinkschulte; U Breyer-Pfaff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

  7 in total
  3 in total

1.  Inhibition of neutrophil activation by alpha1-acid glycoprotein.

Authors:  M J Costello; H Gewurz; J N Siegel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

2.  The binding of ketamine to plasma proteins: emphasis on human plasma.

Authors:  P G Dayton; R L Stiller; D R Cook; J M Perel
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

3.  Plasma protein binding of perazine and amitriptyline in psychiatric patients.

Authors:  M Brinkschulte; H J Gaertner; H W Schied; U Breyer-Pfaff
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.